REGENXBIO Inc. Insider Trading for February 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENXBIO Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENXBIO Inc. for February 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 35.80 | 5,300 | 189,740 | 41,250 | |
| Feb 27 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Sell | S | 54.05 | 5,300 | 286,465 | 39,500 | 44.8 K to 39.5 K (-11.83 %) |
| Feb 27 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 35.80 | 5,300 | 189,740 | 44,800 | 39.5 K to 44.8 K (+13.42 %) |
| Feb 19 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | M | 0.85 | 15,000 | 12,750 | 174,670 | |
| Feb 19 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 47.84 | 8,066 | 385,877 | 246,000 | 254.1 K to 246 K (-3.17 %) |
| Feb 19 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 47.30 | 3,522 | 166,591 | 254,066 | 257.6 K to 254.1 K (-1.37 %) |
| Feb 19 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 45.96 | 3,412 | 156,816 | 257,588 | 261 K to 257.6 K (-1.31 %) |
| Feb 19 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Buy | M | 0.85 | 15,000 | 12,750 | 261,000 | 246 K to 261 K (+6.10 %) |
| Feb 11 2019 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Option Exercise | M | 0.85 | 120,000 | 102,000 | 84,900 | |
| Feb 11 2019 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Buy | M | 0.85 | 120,000 | 102,000 | 242,283 | 122.3 K to 242.3 K (+98.13 %) |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 13.09 | 625 | 8,181 | 2,708 | |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 19.50 | 1,875 | 36,563 | 15,000 | |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 22.00 | 32,882 | 723,404 | 43,219 | |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 35.80 | 8,450 | 302,510 | 46,550 | |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Sell | S | 50.08 | 43,832 | 2,195,107 | 39,500 | 83.3 K to 39.5 K (-52.60 %) |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 13.09 | 625 | 8,181 | 83,332 | 82.7 K to 83.3 K (+0.76 %) |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 19.50 | 1,875 | 36,563 | 82,707 | 80.8 K to 82.7 K (+2.32 %) |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 22.00 | 32,882 | 723,404 | 80,832 | 48 K to 80.8 K (+68.58 %) |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 35.80 | 8,450 | 302,510 | 47,950 | 39.5 K to 48 K (+21.39 %) |
| Feb 05 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | M | 0.85 | 45,000 | 38,250 | 189,670 | |
| Feb 05 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Buy | M | 0.85 | 45,000 | 38,250 | 246,000 | 201 K to 246 K (+22.39 %) |